pre title

Trademarks


Listed below are product trademarks and their owners that appear on the Bristol-Myers Squibb website. Bristol-Myers Squibb trademarks include those of its divisions and subsidiary companies.

 

ABILIFY® (aripiprazole) – Otsuka Pharmaceutical Co., Ltd.
 
ATRIPLA® (efavirenz/emtricitabine/tenofovir disoproxil fumarate) – Gilead Sciences LLC
 
AVAPRO® (irbesartan) – Sanofi
 
AZACTAM® (aztreonam) – Bristol-Myers Squibb Company
 
BARACLUDE® (entecavir) – Bristol-Myers Squibb Company
 
BICNU® (carmustine) – Emcure Pharmaceuticals Limited 
 
*BLENOXANE® (bleomycin sulfate) – Bristol-Myers Squibb Company
 
BUFFERIN  – Genomma Lab USA, Inc.
 
BUSPAR – BMS Co only owns this trademark ex-US (see discussion below about such marks)
 
CAPOTEN® (captopril) – Par Pharmaceutical, Inc
.
CARDIOLITE® (Kit for the preparation of technetium tc99m sestamibi) – Lantheus Medical Imaging, Inc.
 
*CEFZIL® (cefprozil) – Bristol-Myers Squibb Company
 
CEENU – BMS Co only owns this trademark ex-US (see discussion below about such marks)
 
CLAIROL - Noxell Corporation
 
COUMADIN® (warfarin sodium) – Bristol-Myers Squibb Pharma Company
 
DAKLINZA® (daclatasvir) - Bristol-Myers Squibb Company
 
DROXIA® (hydroxyurea) – Bristol-Myers Squibb Company
 
ELIQUIS® (apixaban) – Bristol-Myers Squibb Company
 
EMPLICITI® (elotuzumab) – Bristol-Myers Squibb Company
 
ERBITUX – Imclone LLC
 
ETOPOPHOS® (etoposide phosphate) – Bristol-Myers Squibb Company
 
EVOTAZ® (atazanavir and cobicistat) – Bristol-Myers Squibb Company
 
EXCEDRIN® Migraine – Novartis Consumer Health S.A.
 
GLUCOPHAGE® (metformin hydrochloride) – Merck Sante
 
GLUCOPHAGE XR® EXTENDED RELEASE (metformin hydrochloride) – Merck Sante
 
GLUCOVANCE® (glyburide and metformin hydrochloride) – Merck Sante
 
HYDREA® (hydroxyurea) – Bristol-Myers Squibb Company
 
IPANA® – Maxill, Inc.
 
IXEMPRA® (ixabepilone) – R-Pharm US Operating, LLC 
 
KENALOG®-10 (triamcinolone acetonide) – Bristol-Myers Squibb Company
 
KENALOG®-40 (triamcinolone acetonide) – Bristol-Myers Squibb Company
 
KOMBIGLYZE – AstraZeneca AB 
 
LYSODREN® (mitotane) – Laboratoire HRA-Pharma SAS
 
MEGACE® (megestrol acetate) – Bristol-Myers Squibb Company
 
*METAGLIP® (glipizide and metformin hydrochloride) – Merck Sante
 
*MONOPRIL® (fosinopril sodium) – Bristol-Myers Squibb Company
 
*MUTAMYCIN® (mitomycin) – Bristol-Myers Squibb Company
 
NULOJIX® (belatacept) - Bristol-Myers Squibb Company
 
ONGLYZA – AstraZeneca AB
 
OPDIVO® (nivolumab) – Bristol-Myers Squibb Company
 
ORENCIA® (abatacept) – Bristol-Myers Squibb Company
 
*PARAPLATIN® (carboplatin) – Bristol-Myers Squibb Company
 
PLAVIX® (clopidogrel bisulfate) – Sanofi 
 
PLATINOL – BMS Co.
 
PRAVACHOL® (pravastatin sodium) – Bristol-Myers Squibb Company
 
REYATAZ® (atazanavir sulfate) – Bristol-Myers Squibb Company
 
SAL HEPATICA - Menper Distributors Inc.
 
SINEMET® (carbidopa-levodopa) – Merck Sharpe & Dohme Corp.
 
SINEMET® CR (carbidopa-levodopa) – Merck Sharpe & Dohme Corp
 
SPRYCEL® (dasatinib) – Bristol-Myers Squibb Company
 
SUSTIVA® (efavirenz) – Bristol-Myers Squibb Pharma Company
 
TAXOL® (paclitaxel) – Bristol-Myers Squibb Company
 
*TEQUIN® (gatifloxacin) – Bristol-Myers Squibb Company
 
*VEPESID® (etoposide) – Bristol-Myers Squibb Company
 
VIDEX® (didanosine) – Bristol-Myers Squibb Company
 
VIDEX EC® DELAYED RELEASE (didanosine) – Bristol-Myers Squibb Company
 
YERVOY® (ipilimumab) – Bristol-Myers Squibb Company
 
ZERIT® (stavudine) – Bristol-Myers Squibb Company
 
* Only registered ex-US in the names of the parties listed on the website